{
    "accession": "ENCBS558TFT",
    "age": "15",
    "age_units": "year",
    "applied_modifications": [
        {
            "category": "deletion",
            "method": "CRISPR",
            "modified_site_by_target_id": "SPAG9",
            "purpose": "repression",
            "reagents": [
                {
                    "identifier": "brenton-graveley:BGC#0000881",
                    "source": "/sources/brenton-graveley/"
                }
            ]
        }
    ],
    "biosample_term_id": "EFO:0001187",
    "biosample_term_name": "HepG2",
    "biosample_type": "cell line",
    "characterizations": [
        {
            "references": []
        }
    ],
    "dbxrefs": [],
    "description": "RNA-seq on HepG2 cells treated with a CRISPR gRNA against SPAG9. (SPAG9-BGHcLV31-64)",
    "documents": [
        {
            "attachment": "/documents/e1f15f87-68e6-4a2f-9f0a-94b0c5042aac/@@download/attachment/SPAG9-BGHcLV31-64.pdf",
            "document_type": "general protocol",
            "references": [],
            "urls": []
        }
    ],
    "donor": "ENCDO000AAC",
    "health_status": "hepatocellular carcinoma",
    "lab": "Brenton Graveley, UConn",
    "life_stage": "child",
    "organism": "Homo sapiens",
    "references": [],
    "sex": "male",
    "source": "ATCC",
    "summary": "Homo sapiens HepG2 cell line genetically modified (deletion) using CRISPR targeting H. sapiens SPAG9",
    "treatments": []
}